Expertise in
11
conditions

Dr. Maxwell Krem

Oncology
Curators Of The University Of Missouri
1 Hospital Dr, 
Columbia, MO 
Expertise in
11
conditions
Curators Of The University Of Missouri
1 Hospital Dr, 
Columbia, MO 

Overview

Maxwell Krem is an Oncologist in Columbia, Missouri. Dr. Krem is highly rated in 11 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft.

His clinical research consists of co-authoring 46 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Oncology

Licenses

Internal Medicine in KY

Hospital Affiliations

University Of Missouri Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

Curators of the University of Missouri
1 Hospital Dr, Columbia, MO 65212

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Phase III Trial of Consolidation With Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs Maintenance Rituximab Alone for Patients With Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission
A Randomized Phase III Trial of Consolidation With Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs Maintenance Rituximab Alone for Patients With Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Biological, Procedure
Study Drug: Rituximab
Study Phase: Phase 3
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Drug, Biological, Procedure, Other, Radiation
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Filgrastim, Nivolumab, Pegfilgrastim, Vinblastine
Study Phase: Phase 3
Phase 2 Study of Copanlisib in Combination With Nivolumab in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Phase 2 Study of Copanlisib in Combination With Nivolumab in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Enrollment Status: Completed
Publish Date: March 03, 2025
Intervention Type: Biological, Drug
Study Drugs: Copanlisib Hydrochloride, Nivolumab
Study Phase: Phase 2
A Multicenter, Randomized, Open-label Phase 2 Study Evaluating the Safety and Efficacy of Three Different Regimens of Oral Panobinostat in Combination With Subcutaneous Bortezomib and Oral Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Who Have Been Previously Exposed to Immunomodulatory Agents
A Multicenter, Randomized, Open-label Phase 2 Study Evaluating the Safety and Efficacy of Three Different Regimens of Oral Panobinostat in Combination With Subcutaneous Bortezomib and Oral Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Who Have Been Previously Exposed to Immunomodulatory Agents
Enrollment Status: Completed
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drugs: Panobinostat Capsules, Bortezomib Injection, Dexamethasone Tablets
Study Phase: Phase 2
Phase 2 Trial of the Heat Shock Protein-90 (Hsp90) Inhibitor AT13387 (Onalespib) in Patients With Relapsed/Refractory ALK+ ALCL, Mantle Cell Lymphoma, and BCL6+ DLBCL
Phase 2 Trial of the Heat Shock Protein-90 (Hsp90) Inhibitor AT13387 (Onalespib) in Patients With Relapsed/Refractory ALK+ ALCL, Mantle Cell Lymphoma, and BCL6+ DLBCL
Enrollment Status: Terminated
Publish Date: September 13, 2022
Intervention Type: Drug
Study Drug: Onalespib
Study Phase: Phase 2
View 4 Less Clinical Trials

46 Total Publications

Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis.
Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis.
Journal: Blood advances
Published: September 23, 2024
Similar Doctors
Expertise in
87
conditions
Dr. Umasankar Ramadoss
Hematology | Oncology
Expertise in
87
conditions
Dr. Umasankar Ramadoss
Hematology | Oncology

Missouri Cancer Associates Rrl

1705 E Broadway Ste 100, 
Columbia, MO 
 (5.4 miles away)
573-874-7800
Languages Spoken:
English
See accepted insurances

Umasankar Ramadoss is a Hematologist and an Oncologist in Columbia, Missouri. Dr. Ramadoss is highly rated in 87 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, Bone Marrow Aspiration, and Liver Embolization.

Expertise in
100
conditions
Dr. Elangovan Balakrishnan
Oncology
Expertise in
100
conditions
Dr. Elangovan Balakrishnan
Oncology

Missouri Cancer Associates Rrl

1705 E Broadway Ste 100, 
Columbia, MO 
 (5.4 miles away)
660-785-1050
Languages Spoken:
English
See accepted insurances

Elangovan Balakrishnan is an Oncologist in Columbia, Missouri. Dr. Balakrishnan is highly rated in 100 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, Bone Marrow Aspiration, and Endoscopy.

Mark Tungesvik
Expertise in
76
conditions
Dr. Mark Tungesvik
Oncology
Expertise in
76
conditions
Dr. Mark Tungesvik
Oncology

Missouri Cancer Associates Rrl

1705 E Broadway Ste 100, 
Columbia, MO 
 (5.4 miles away)
573-874-7800
Languages Spoken:
English
See accepted insurances

Mark Tungesvik is an Oncologist in Columbia, Missouri. Dr. Tungesvik is highly rated in 76 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, Bone Marrow Aspiration, and Endoscopy.

Frequently Asked Questions about Dr. Maxwell Krem

How do I make an appointment with Dr. Maxwell Krem?

You can book an appointment with Dr. Maxwell Krem by calling their office at 573-882-8445. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Maxwell Krem a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Maxwell Krem is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Maxwell Krem specialize in?

While Dr. Maxwell Krem is a Oncology, they have specific expertise in Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Maxwell Krem participate in research or clinical trials?

Yes. Dr. Maxwell Krem has published 46 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Maxwell Krem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Maxwell Krem accept my insurance?

Dr. Maxwell Krem accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 573-882-8445 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krem's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 53 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile